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This study examined the interaction of mouse bone marrow mesenchymal stem cells (MSC) with cardiac HL-1 cells during coculture
by fluorescent dye labeling and then flow cytometry. MSC were layered onto confluent HL-1 cell cultures in a 1 : 4 ratio. MSC gained
gap junction permeant calcein from HL-1 cells after 4 hours which was partially reduced by oleamide. After 20 hours, 99% MSC
gained calcein, unaffected by oleamide. Double-labeling HL-1 cells with calcein and the membrane dye DiO resulted in transfer
of both calcein and DiO to MSC. When HL-1 cells were labeled with calcein and MSC with DiO, MSC gained calcein while HL-1
cells gained DiO. Very little fusion was observed since more than 90% Sca-1 positive MSC gained DiO from HL-1 cells while less
than 9% gained gap junction impermeant CMFDA after 20 hours with no Sca-1 transfer to HL-1 cells. Time dependent transfer of
membrane DiD was observed from HL-1 cells to MSC (100%) and vice versa (50%) after 20 hours with more limited transfer of
CMFDA. These results demonstrate that MSC and HL-1 cells exchange membrane components which may account for some of the
beneficial effect of MSC in the heart after myocardial infarction.

1. Introduction
We have previously shown that injection of mouse bone
marrow mesenchymal stem cells (MSC) prevents the loss of
function that occurs in mouse hearts after coronary artery
occlusion [1]. The mechanism for this protective effect is
unclear since there was no reduction in ventricular scarring
or evidence of cardiomyocyte differentiation in integrated
MSC. We have recently shown that MSC secrete a variety
of cytokines that have a significant effect on angiogenesis,
apoptosis, and cell migration [2] supporting the hypothesis
that MSC protect the heart, at least in part, by secreting
paracrine factors [3].
Ventricular myocytes exhibit extensive gap junctions formation [4] which provides electrical coupling and the transfer
of small molecules between cells (<1 kD) [5, 6]. MSC express
connexins and are able to form gap junctions with cardiac
ventricular myocytes [7] and HL-1 cardiac cells [8]. Thus,

gap junctions may provide a conduit for the cardioprotective
effects of MSC in the heart [8, 9].
In addition, cells are able to communicate with the
exchange of cytoplasmic and membrane components by the
formation of tunneling nanotubes [10] or extracellular vesicles [11]. Nanotubes are 50–200 nm diameter membranous
channels containing F-actin that form a cytoplasmic connection between cells [12]. Extracellular vesicles are heterogeneous and include exosomes, microvesicles, and ectosomes
which vary by their size and cellular origin [13, 14]. In addition
to the secretion of cytokines, nanotubes and vesicles may play
an important role in the cardioprotective effect of MSC in the
heart [15–19].
In the current study, we examined the interaction of
MSC with cardiac HL-1 cells in a coculture system. Although
we were looking for the transfer of small cytoplasmic components via gap junctions, we found significant transfer of
membrane components.
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2. Methods
2.1. MSC and HL-1 Cell Culture. Mouse bone marrow mesenchymal stem cells (MSC; passages 20–25) were cultured in
10 cm plates at 1.0 × 106 cells/plate as previously described [1]
in complete mouse Mesencult media (basal media + stimulatory supplement; Stem Cell Technologies) until confluent.
Cells were then fluorescently labeled and subsequently lifted
with 0.25% trypsin-EDTA for coculture with HL-1 cells.
Cardiac HL-1 cells were generously supplied by W.C.
Claycomb and cultured according to previously published
specifications [20]. Cells were cultured in 6-well plates coated
with 0.02% gelatin + 0.05% fibronectin at 0.8 × 106 cells/well
in complete Claycomb media (Claycomb media (Sigma) +
10% FBS + 0.1 mM norepinephrine + 2 mM glutamine +
100 U/mL penicillin + 100 𝜇g/mL streptomycin) until the cells
were confluent. Cells were then fluorescently labeled prior to
coculture with MSC.
MSC or HL-1 monolayers were labeled with various fluorescent dyes prior to coculture. Cells were washed 2 times in
PBS to remove serum and then incubated with dye in DMEM
(MSC) or Claycomb base media (HL-1) containing no serum
or other additives. Following dye labeling, cells were washed
in PBS. Cells were subsequently labeled with 2.5 𝜇M of
the cytoplasmic gap junction permeant calcein red-orange
AM (Cell Trace; Molecular Probes/Invitrogen, C34851) for
1 hour, 5 𝜇M of the cytoplasmic gap junction impermeant chloromethyl fluorescein diacetate (Cell Tracker Green
CMFDA; Molecular Probes/Invitrogen, C7025) for 1 hour
(with a media replacement after 30 minutes), or 5 𝜇M of the
membrane labeling carbocyanine dyes DiO or DiD (Vibrant
Cell Labeling Solution; Molecular Probes/Invitrogen, V22886, V-22887) for 1 hour. In addition, in some experiments
MSC were labeled in suspension with anti-mouse-Sca1-PEcy5
(eBiosciences, 15-5981) for 1 hr and washed in PBS + 0.25%
BSA+ 2 mM EDTA prior to use. Controls were incubated with
a mouse isotype control instead.
After labeling, MSC and HL-1 cells were cocultured
for 4 or 20 hours. MSC were resuspended in complete
Claycomb media and 0.25 × 106 MSC were layered onto
confluent HL-1 cultures (1.0–1.5 × 106 HL-1 cells/well) in 6well plates. Following coculture, cells were washed in PBS,
lifted with 0.25% trypsin-EDTA, centrifuged, resuspended
in 3 mL PBS/BSA/EDTA, passed through a 100 𝜇M filter,
centrifuged, and resuspended in 100 𝜇L PBS/BSA/EDTA for
analysis by flow cytometry. Flow cytometry was performed in
the UIC Research Resources Center, Flow Cytometry Service,
using the BD LSRFortessa Cell Analyzer. Data was analyzed
using Summit 4.3 software. All coculture experiments were
replicated at least 4 times and the percentage of labeled cells
was determined as mean ± s.e.m.; significance was assessed
using Student’s 𝑡-test.
2.2. H9c2 Cell Scrape Loading. Cardiac myoblast H9c2
cells (ATCC number CRL-1446) were cultured in
fibronectin/gelatin coated 6-well plates at 0.3 × 106 cells/well
in DMEM + 10% FBS for 72 hours in the presence or absence
of 50 𝜇M oleamide. Confluent cultures were then scrape
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loaded with Lucifer yellow or dextran-Rhodamine B [6].
Specifically, the wells were washed twice with calcium-free
PBS and then 0.05% Lucifer yellow dipotassium salt (Sigma)
or 0.1% dextran-Rhodamine B (10,000 MW; Invitrogen) in
calcium-free PBS was added. After scraping a single line with
a 29 gauge needle and incubating for 7 minutes, the cultures
were washed three times in PBS + 1.5 mM Ca++ and observed
using an inverted fluorescent microscope.

3. Results
3.1. Detection of Gap Junctions. In order to study the formation of gap junctions between MSC and HL-1 cells,
confluent cultures of HL-1 cells were double labeled with the
cytoplasmic gap junction impermeant dye CMFDA and the
gap junction permeant dye calcein red-orange AM (Figure 1).
Unlabeled MSC were then layered on top of the confluent
labeled HL-1 cells in a 1 : 4 ratio to mimic the lower number of
transplanted MSC compared to endogenous myocytes when
used in vivo. Analysis by flow cytometry after 4 hours of
coculture demonstrated that 23.3 ± 2.2% of the MSC gained
calcein while no CMFDA was transferred (Figures 1(a)–1(c)).
Treatment of MSC with 50 𝜇M oleamide, a gap junction
blocker [21, 22], for 10 minutes prior to and during coculture
significantly reduced the amount of calcein transfer to 16.6 ±
2.0%, indicating that at least some transfer of calcein was
due to the formation of gap junctions. Coculture for 20
hours resulted in transfer of calcein to 99.8 ± 0.1% of MSC
(Figures 1(d)–1(f)); interestingly, oleamide treatment had no
effect after 20 hours, suggesting that gap junctions were not
involved in calcein transfer after 20 hours.
Since oleamide did not completely block calcein transfer,
we wanted to confirm that 50 𝜇M oleamide is sufficient to
block gap junctions. Cardiac H9c2 cells, known to form
functional gap junctions [23], were cultured in the presence
or absence of 50 𝜇M oleamide and then scrape loaded with
Lucifer yellow upon confluence. In the absence of oleamide,
Lucifer yellow was transferred 10–30 cell layers away from
the scrape (Figure 2(a)). In the presence of oleamide, Lucifer
yellow was only transferred 1-2 cell layers from the scrape
(Figure 2(b)). Scrape loading with gap junction impermeant
dextran-Rhodamine B demonstrated a lack of dye transfer
to any cell layers away from the scrape (Figure 2(c)). These
results demonstrate that 50 𝜇M oleamide is sufficient to block
gap junctions.
In separate experiments, confluent cultures of HL-1 cells
were double labeled with the membrane dye DiO along
with calcein and then unlabeled MSC were layered on top
in a 1 : 4 ratio as before and cocultured for 4 hours. After
flow cytometry, a completely different pattern was observed
(Figure 3). Not only was there a shift in fluorescence of the
MSC population denoting a gain of calcein as before but
also the MSC population appeared to gain DiO suggesting a
transfer of membrane.
In order to further assess the phenomenon of a gain
in DiO, confluent cultures of HL-1 cells were labeled with
calcein while MSC were labeled with DiO. The MSC were
then layered onto the HL-1 cells in a 1 : 4 ratio and cocultured
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Figure 1: Flow cytometry of unlabeled MSC and CMFDA/calcein labeled HL-1 cells after 4 and 20 hours of coculture. (a–c) Four hours of
coculture. (d–f) 20 hours of coculture. (a) and (d) Unlabeled MSC (M) prior to coculture. (b) and (e) HL-1 cells (H) double labeled with
CMFDA and calcein prior to coculture. (c) and (f) Unlabeled MSC and CMFDA/calcein labeled HL-1 cells after coculture.

(a)

(b)

(c)

Figure 2: Scrape loading of H9c2 cells. (a) Scrape loading with Lucifer yellow in the absence of oleamide. (b) Scrape loading with Lucifer
yellow in the presence of oleamide. (c) Scrape loading with dextran-Rhodamine B in the absence of oleamide. Arrow: edge of scrape.

for 4 and 20 hours (Figure 4). After 4 hours some of the
MSC gained calcein from the HL-1 cells (Figure 4(c-4)).
However, after 20 hours (Figure 4(c-20)), all of the MSC
gained cytoplasmic calcein from the HL-1 cells, while some
of the HL-1 cells also gained membrane DiO from the MSC.

We concluded from these experiments that gap junctions
could account for the transfer of some calcein. However, the
data suggests that another mechanism was also responsible since oleamide was unable to completely block calcein
transfer after 4 hours and was ineffective after 20 hours. In
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Figure 3: Flow cytometry of unlabeled MSC and DiO/calcein labeled HL-1 cells after 4 hours of coculture. (a) Unlabeled MSC (M) prior to
coculture. (b) HL-1 cells (H) double labeled with DiO and calcein prior to coculture. (c) Unlabeled MSC and DiO/calcein labeled HL-1 cells
after 4 hours of coculture.
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Figure 4: Flow cytometry of DiO labeled MSC and calcein labeled HL-1 cells after 4 and 20 hours of coculture. (a) HL-1 cells (H) labeled
with calcein prior to coculture. (b) MSC (M) labeled with DiO prior to coculture. (c-4) DiO labeled MSC and calcein labeled HL-1 cells after
4 hours of coculture. (c-20) DiO labeled MSC and calcein labeled HL-1 cells after 20 hours of coculture.
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Figure 5: Flow cytometry of Sca1-PEcy5 labeled MSC and DiO or CMFDA labeled HL-1 cells after 20 hours of coculture. (a) MSC (M) labeled
with Sca1-PEcy5 prior to coculture. (b) DiO: HL-1 cells (H) labeled with DiO prior to coculture. (c) DiO: Sca1-PEcy5 labeled MSC and DiO
labeled HL-1 cells after 20 hours of coculture. (b) CMFDA: HL-1 cells (H) labeled with CMFDA prior to coculture. (c) CMFDA: Sca1-PEcy5
labeled MSC and CMFDA labeled HL-1 cells after 20 hours of coculture.

addition, membrane components (DiO) were being transferred after 4 and 20 hours.
3.2. Test for Fusion of MSC with HL-1 Cells. We reasoned
that MSC might be fusing with HL-1 cells, causing the

transfer of membrane components between MSC and HL-1
cells. In order to test this hypothesis, MSC were labeled
with the stem cell membrane marker Sca1 using anti-Sca1PEcy5. HL-1 cells were labeled with either membrane DiO or
cytoplasmic CMFDA. MSC were then layered onto confluent

6

Stem Cells International
104

104

104

M

M
103

102

103
DiD log

DiD log

DiD log

103

102
101

101
100
100

10

1

2

10
10
CMFDA log

3

10

100
100

4

101
H
101

(a)

10

4

10

3

102

102
103
CMFDA log

100
100

104

H

101

(b)

10

4

10

3

102
103
CMFDA log
(c)

10

4

102
101

101
100
100

103
DiD log

DiD log

DiD log

H

102

M
101

102
103
CMFDA log

104

100
100

104

H
M

102
101

101

(d)

102
103
CMFDA log
(e)

104

100
100

101

102
103
CMFDA log

104

(f)

Figure 6: Flow cytometry of DiD/CMFDA labeled MSC and unlabeled HL-1 cells or unlabeled MSC and DiD/CMFDA labeled HL-1 cells
after 20 hours of coculture. (a) MSC (M) labeled with DiD and CMFDA prior to coculture. (b) Unlabeled HL-1 cells (H) prior to coculture.
(c) DiD/CMFDA labeled MSC and unlabeled HL-1 cells after 20 hours of coculture. (d) Unlabeled MSC (M) prior to coculture. (e) HL-1 cells
(H) labeled with DiD and CMFDA prior to coculture. (f) Unlabeled MSC and DiD/CMFDA HL-1 cells after 20 hours of coculture.

HL-1 cultures in a 1 : 4 ratio, cocultured for 20 hours, and
analyzed by flow cytometry (Figure 5). We theorized that
if fusion occurred, then both DiO and CMFDA would be
transferred to the MSC labeled with Sca1. However, if fusion
did not occur, then the cytoplasmic CMFDA would remain
limited to the HL-1 cells. As shown in Figure 5(a), 76% of the
MSC were Sca1 positive. Coculture with DiO labeled HL-1
cells demonstrated 92.4 ± 0.6% transfer of membrane DiO
to Sca1 positive MSC (Figure 5(b), DiO; Figure 5(c), DiO).
Coculture with CMFDA labeled HL-1 cells showed only 8.8 ±
0.5% of the Sca1 positive MSC gained cytoplasmic CMFDA
(Figure 5(b), CMFDA; Figure 5(c), CMFDA). There was no
apparent transfer of Sca1 to HL-1 cells.
These results indicated to us that there may be a small
amount of fusion of MSC with HL-1 cells due to the limited
transfer of cytoplasm; however, there was a large transfer of
membrane components from HL-1 cells to MSC.
3.3. Test for Membrane Transfer between MSC and HL-1 Cells.
To determine the time course and amount of membrane

transfer, MSC were layered onto confluent cultures of HL-1
cells in a 1 : 4 ratio after labeling with different combinations
of membrane DiD and cytoplasmic CMFDA. In one group
the MSC were double labeled with membrane DiD and
cytoplasmic CMFDA and the HL-1 cells were unlabeled.
In the second group, the HL-1 cells were double labeled
while the MSC were unlabeled (Figure 6). Since our goal
was to monitor membrane transfer, CMFDA was used to
label the cytoplasm because cytoplasmic calcein was readily
transferred between cells. The cells were then cocultured for
4 and 20 hours.
When the MSC were double labeled, coculture with unlabeled HL-1 cells for 20 hours (Figures 6(a)–6(c), Figure 7)
demonstrated that 47.5 ± 0.8% of the HL-1 cells gained
membrane DiD from the MSC; there was no detectable
transfer of cytoplasmic CMFDA from the MSC to the HL-1
cells. After 4 hours (Figure 7) only 6.4 ± 0.2% unlabeled HL1 gained membrane DiD from double labeled MSC; again,
these cells did not pick up any cytoplasmic CMFDA.
When the MSC were unlabeled and HL-1 cells were
double labeled, coculture for 20 hours (Figures 6(d)–6(f),
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Figure 7: Percent cells that gained membrane or cytoplasm after 4 and 20 hours of coculture of MSC and HL-1 cells. MSC and HL-1 cells
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cytoplasm (CMFDA label) during coculture as determined by flow cytometry. MSC → HL-1 = transfer from MSC to HL-1 cells (open bars).
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Figure 7) demonstrated that 100% of the MSC gained membrane DiD from the HL-1 cells. In addition, 13.4 ± 0.9% of
the MSC gained cytoplasmic CMFDA from the HL-1 cells.
After 4 hours (Figure 7), 88.2 ± 0.4% unlabeled MSC gained
membrane DiD from double labeled HL-1 cells; 4.7 ± 0.1% of
the MSC gained cytoplasmic CMFDA.

4. Discussion
This study clearly demonstrates for the first time that MSC
and HL-1 cells exchange membrane components in a timedependent manner when cocultured. We found that 100%
of the MSC gained membrane from the HL-1 cells after 20
hours while 48% of the HL-1 cells gained membrane from the
MSC. This smaller amount of membrane component transfer
to HL-1 cells is consistent with our experimental design since
there were 80% fewer MSC than HL-1 cells resulting in a
lower probability for MSC to exchange membrane with HL-1
cells. It is interesting that while the membrane lipid dyes DiO
and DiD transferred between the cells, the Sca1 membrane
protein did not transfer from the MSC to the HL-1 cells. One
plausible explanation for this finding is a selective transfer
of membrane components [13] between MSC and HL-1 cells.
It is probable that the membranes were exchanged due to
the close contact between the MSC and HL-1 cells during
coculture since MSC were layered on top of confluent HL1 cells. Possible cellular mechanisms that could account for
this exchange include tunneling nanotubes as seen between
MSC and cardiomyocytes [24] or the exchange of exosomes
or microvesicles, consistent with a previous report of MSC
and nucleus pulposis cell coculture [25].

This study also suggests the formation of gap junctions
between MSC and HL-1 cells during the early stages of
coculture. After 4 hours some of the calcein dye transfer was
oleamide sensitive. This is consistent with the work of Mureli
and coworkers [8] who found that MSC began to form gap
junctions within 20 minutes when cocultured with HL-1 cells,
46% formed junctions after 4 hours and 60% after 24 hours.
In our study 100% of the MSC were found to have gained
calcein from the HL-1 cells after 20 hours, a transfer that was
oleamide insensitive. This suggests that calcein transfer was
initially due, in part, to gap junctions but later occurred by
alternate means most likely in conjunction with the observed
membrane transfer.
We found that approximately 10% of MSC gained the gap
junction impermeant dye CMFDA from HL-1 cells indicating
a low level of fusion between MSC and HL-1 cells. Although
we did not detect CMFDA transfer from MSC to HL-1 cells,
this is most likely due to the lower numbers of MSC compared
to HL-1 cells. Whether or not fusion of MSC with resident
cells accounts for observed transdifferentiation of MSC into
cardiomyocytes has been a persistent question [26, 27]. Our
results, coupled with those for cardiomyocytes [28], neural
cells [29], and the nucleus pulposis [25] show that fusion
events, if they occur at all, are quite rare.
It now appears that the cardioprotective effect of MSC
may be multifaceted. Although there is evidence that MSC
are able to differentiate into a cardiomyocyte phenotype
[30–32], much of the beneficial effect is probably due to
alternate mechanisms [33]. First, work in our laboratory [2]
and others [3, 15] has clearly shown that MSC secrete a variety
of cytokines that are able to affect migration, angiogenesis,
apoptosis, and the immune reaction. Second, the current
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study along with that of Mureli et al. [8] demonstrated
the rapid formation of gap junctions after coculture. Gap
junctions not only provide electrical coupling between MSC
and cardiomyocytes [7, 8] but also could function to exchange
other molecules that are important in the differentiation of
MSC into a cardiomyocyte lineage [34]. Third, paracrine
communication by MSC via extracellular vesicles (exosomes
and microvesicles) is now well established [11], and exosomes
from MSC have a beneficial effect on the heart after ischemiareperfusion injury [16]. These vesicles are able to transport
a wide variety of molecules such as membrane components,
mRNA, miRNA, and signaling molecules between various
types of cells [13, 14]. This exosomal transfer may be bidirectional since cardiomyocytes produce exosomes containing a
wide variety of mRNA that affect fibroblast gene transcription
[35]. Fourth, it is becoming increasingly clear that cells are
able to communicate through the formation of tunneling
nanotubes [12]. Nanotubes allow for electrical coupling and
the transfer of membrane and cytoplasmic components
between cells [10, 36]. Nanotube connections between MSC
and cardiomyocytes [24] allow the transfer of mitochondria
[17], revert the differentiation state of cardiomyocytes toward
a progenitor state [18], and alter the secretion of paracrine
factors by MSC [19]. The membrane transfer observed in our
study may be due to the exchange of extracellular vesicles or
the formation of tunneling nanotubes between MSC and HL1 cells.

5. Conclusion
This study demonstrates that MSC are able to exchange
membrane components with HL-1 cardiac cells. Exchange of
this nature may account for some of the beneficial effect we
observed when MSC were injected into mice with surgically
induced permanent coronary artery occlusion [1] in addition
to the previously reported secretion of cytokines by MSC
[2]. Future studies will focus on the mechanism of transfer
and the specific molecules exchanged between these cells and
their potential function.
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